Findings demonstrated that fremanezumab significantly reduced the use of acute headache medications and the frequency of migraine-associated symptoms in patients with episodic migraine compared with placebo.:
Source: Neurology Read More
Fremanezumab Reduces Acute Medication Use and Migraine Symptoms in Episodic Migraine, Phase 2b/3 Trial Shows
Related Posts
<![CDATA[Phase 3 Post Hoc Analysis Shows
Foslevodopa/Foscarbidopa Reduces Troublesome Dyskinesia in Advanced
Parkinson Disease ]]>
<![CDATA[Phase 3 Post Hoc Analysis Shows Foslevodopa/Foscarbidopa Reduces Troublesome Dyskinesia in Advanced Parkinson Disease ]]>
